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ABSTRACT
Background: Chronic fatigue syndrome/myalgic
encephalomyelitis (CFS/ME), in its most severe clinical
presentation, can result in patients becoming
housebound and bedbound so unable to access most
available specialist services. This presents particular
clinical risks and treatment needs for which the
National Institute for Health and Care Excellence (NICE)
advises specialist medical care and monitoring. The
extent of National Health Service (NHS) specialist
provision in England for severe CFS/ME is currently
unknown.
Objectives: To establish the current NHS provision
for patients with severe CFS/ME in England.
Setting and participants: All 49 English NHS
specialist CFS/ME adult services in England, in 2013.
Method: Cross-sectional survey by email
questionnaire.
Primary outcome measures: Adherence to NICE
guidelines for severe CFS/ME.
Results: All 49 services replied (100%). 33% (16/49)
of specialist CFS/ME services provided no service for
housebound patients. 55% (27/49) services did treat
patients with severe CFS/ME and their interventions
followed the NICE guidelines. The remaining services
(12%, 6/49) offered occasional or minimal support where
funding allowed. There was one NHS unit providing
specialist inpatient CFS/ME provision in England.
Conclusions: Study findings highlight substantial
variation in access to specialist care for patients with
severe presentation of CFS/ME. Where treatment was
provided, this appeared to comply with NICE
recommendations for this patient group.
INTRODUCTION
Chronic fatigue syndrome, also known as
myalgic encephalomyelitis (CFS/ME), is an
illness characterised by debilitating physical
and mental fatigue, pain and other symp-
toms. It is estimated to affect up to 250 000
people in the UK.1 At its most severe,
CFS/ME can lead to individuals becoming
housebound, wheelchair user or bedbound
and dependent on carers for all basic activ-
ities of daily living.2 The illness can last for
decades, leaving many severely affected indi-
viduals profoundly disabled for many years,
although others return to health within a
much shorter time. There has been little
research to establish the prevalence or prog-
nosis of severe CFS/ME.3
Severe CFS/ME presents particular clinical
risks, as noted by the NICE guidelines.1
Patients who are bedridden for a long period
may have associated medical risks, including
postural hypotension, deep venous throm-
bosis, osteoporosis, pressure sores and decon-
ditioning. Symptoms including malaise and
nausea, combined with impaired physical
mobility for tasks of daily living have led to
reported instances of patients becoming
dehydrated or critically underweight, leading
to emergency hospital admissions. The NICE
guidelines recommend that all patients with
severe CFS/ME receive specialist medical
Strengths and limitations of this study
▪ Our survey received a 100% response from the
49 chronic fatigue syndrome/myalgic encephalo-
myelitis specialist services in the National Health
Service (NHS) in England and all data queries
were resolved via telephone or email.
▪ The study collected data on adult specialist CFS/
ME services only. Further research is needed to
determine paediatric service provision.
▪ While this study collected data on service provi-
sion, it did not collect data on clinical outcomes
for treated patients. This limitation should be
addressed by further research.
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care to monitor clinical risks, and to advise on individu-
ally tailored treatment plans.1
While signiﬁcant progress has been made in research-
ing and treating CFS/ME in mild-to-moderately affected
individuals, housebound patients are generally too ill to
travel to outpatient appointments for treatment. There
has been little formal research conducted on this
patient group, as highlighted by successive national
reports on CFS/ME.1 4 Nevertheless, case reports, pilot
studies and anecdotal evidence suggest that substantial
improvement or recovery is possible for some patients
given specialist intervention individualised to patient
need.2 5 6 Within this context, what specialist care is cur-
rently provided by the National Health Service (NHS) in
England for this patient group?
Our searches of published literature and consultation
with national organisations indicated that no systematic
data had been collected to date on this question. The
aim of this scoping exercise was to ascertain current
service provision within the NHS for severe CFS/ME
within England. This study was conducted as part of a
PhD doctoral fellowship funded by the National
Institute for Health Research (NIHR) School for
Primary Care Research. The team comprised independ-
ent researchers and representatives from the British
Association for CFS/ME (BACME), which is the national
‘umbrella organisation’ representing specialist NHS
CFS/ME services in the UK (http://www.bacme.info).
Background to study
In 2013, there were 49 specialist adult CFS/ME services
in the NHS in England.7 While all specialist CFS/ME
NHS services in the UK follow the 2007 National
Institute for Health and Care Excellence (NICE) guide-
lines for diagnosing and treating CFS/ME, each service
is autonomous in how they choose to implement this
guidance in clinical practice. The 2007 NICE guidelines
on CFS/ME offer ‘general principles of care’ for severe
CFS/ME (summarised in box 1).1
METHOD
This scoping exercise was a cross-sectional study con-
ducted by an emailed questionnaire. Questionnaire
design was guided by existing research literature, discus-
sions with specialist health professionals and consult-
ation with two patient support groups who provided
Patient and Public Involvement (PPI) for the study (The
Association of Young People with ME and the Dorset
ME Support Group).
In this study, we deﬁned ‘severe CFS/ME’ as patients
who are predominantly housebound or bedridden, in
accordance with the Cox and Findley8 severity categories
for CFS/ME.
Data collection
Identiﬁcation of services was conducted between
January and February 2013 from a list provided by the
British Association for CFS/ME cross-checked against
lists of specialist CFS/ME services compiled by ME
support groups. Initial contact with services was made by
telephone or email between February and March 2013.
We asked services to return the completed questionnaire
and consent form by post, email or by telephone with a
researcher. All services replied giving a 100% response
rate. We sent participants who completed the question-
naire by telephone a copy of their questionnaire answers
to verify and return with consent form. Figure 1 provides
a ﬂowchart of data collection.
RESULTS
All 49 specialist CFS/ME adult services in the NHS in
England replied.
Twenty-seven of 49 services (55%) regularly provided
face-to-face therapy and support to severely affected
CFS/ME patients. Of these, 26 provided home visits and
1 offered specialist inpatient CFS/ME treatment. Sixteen
of 49 (33%) were not able to offer any service to house-
bound patients. The most commonly reported reason
for this was lack of funding.
Three of 49 (6%) services provided neither home
visits nor inpatient care, but did give advice/support by
telephone or email to severely affected patients on a
regular basis. These were deﬁned as providing a ‘regular
but minimal service’.
Three of 49 (6%) services reported that they very
occasionally provided help to severely affected patients.
Box 1 NICE 2007 guidelines on severe chronic fatigue
syndrome/myalgic encephalomyelitis (CFS/ME) (extract,
page number 305)
General principles of care
▸ Management of severe CFS/ME is difficult and complex and
healthcare professionals should recognise that specialist
expertise is needed when planning and providing care for
people with severe CFS/ME.
▸ Diagnosis, investigations, management and follow-up care for
people with severe CFS/ME should be supervised or supported
by a specialist in CFS/ME.
▸ When making decisions about prolonged bed rest, healthcare
professionals should seek advice from a specialist experienced
in the care of people with severe CFS/ME. The significant
physical and psychological risks associated with prolonged
bed rest should be taken into account.
▸ Healthcare professionals working with people with severe CFS/
ME who are in bed most (or all) of the time, should explain
the associated risks (such as postural hypotension, deep
venous thrombosis, osteoporosis, pressure sores and decon-
ditioning) and monitor these.
▸ People with severe CFS/ME should be offered an individually
tailored activity management programme as the core thera-
peutic strategy, which may be delivered at home, or using tele-
phone or email if appropriate, drawing on the principles of
cognitive–behavioural therapy (CBT) and graded exercise
therapy (GET).
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These results are summarised in ﬁgure 2.
The study identiﬁed only one NHS specialist inpatient
unit in England providing treatment for patients with
CFS/ME. This eight-bed unit accepts extracontractual
(ie, ‘out of area’) referrals from across the UK. In add-
ition, clinicians from four CFS/ME services reported
contributing to the care of patients who had been admit-
ted as inpatients to other hospital settings. Examples
included a patient admitted to a general medical ward
for comorbidities and another admitted for acute dehy-
dration and weight loss.
Questionnaire data were analysed from the 30 CFS/
ME services which provided a regular service to severely
affected patients (27 services which provided inpatient
or domiciliary care, +3 services which provided
‘minimal’ care by telephone or email). All services com-
pleted the questionnaire. Questionnaires were returned
by post (n=15), email (n=9), telephone (n=5) or in
person (n=1). All missing data or data queries were
resolved by phone or email. This process was completed
by August 2013.
Referral pathways
All 30 services accepted general practitioner (GP) refer-
rals. In addition, 20/30 services accepted referrals from
tertiary care (ie, hospital specialists) and 12/30 services
Figure 1 Flow chart of data
collection.
Figure 2 Provision of care for severely affected patients by
specialist National Health Service chronic fatigue syndrome/
myalgic encephalomyelitis (CFS/ME) services England, 2013.
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accepted out of area or ‘extracontractual’ referrals, pro-
vided that these were funded by the patient’s own
Clinical Commissioning Group.
Diagnostic criteria
Twenty-three of 30 (77%) used the Centers for Disease
(CDC) 1994 (Fukuda) criteria9 making this the most
common case deﬁnition for diagnosis. Ten services used
the CDC 1994 criteria and the recent NICE 2007 cri-
teria.1 Five services used the NICE 2007 criteria only.
Three services offered no diagnostic service and only
accepted referrals from patients with prior diagnosis.
Caseload
Twenty-six of 30 (87%) services provided caseload
ﬁgures. Four services reported that they were unable to
provide this information because their database or other
data collection methods did not categorise according to
illness severity.
The average (mean) caseload was 16 patients (median
n=10, range 3–90). The largest caseload was approxi-
mately 90 patients, reported by a service commissioned
with the speciﬁc remit of offering treatment to patients
at the severe end of the CFS/ME spectrum. All reported
ﬁgures were for total caseload. Discharge policy varied
between services, with some allowing patients to remain
registered with the service for many years after initial
intervention, and others discharging patients after much
shorter periods. In general, higher caseloads tended to
be reported by services which allowed patients to remain
registered for longer periods. The total sum of severely
affected patients on caseloads reported by all the ser-
vices in England combined was 408 patients. We also
asked services how many severely affected patients were
on their waiting list. However, most reported that this
was difﬁcult to determine, since illness severity tended
to be categorised at ﬁrst appointment.
Treatment approach
All 30 services reported that they used more than one
treatment approach in combination. The most com-
monly reported treatment approaches were activity man-
agement which was used by 28/30 (93%) services;
cognitive–behavioural therapy (CBT) used by 25/30
(83%) services and graded activity used by 24/30 (80%)
services.
Participants reported tailoring treatment to individual
patient need, drawing on a range of available therapies.
Results are shown below in table 1.
Many respondents provided free-text comments that
highlighted variations in how different services inter-
preted some of these therapeutic terms. For example,
while 83% of services reported that they used ‘CBT’,
some respondents annotated this answer to comment
that they incorporated some CBT-based approaches on
exploring beliefs and thinking patterns, but did not have
a qualiﬁed CBT therapist on the clinical team.
Similar variations in the use of terminology became
apparent with the term ‘pacing’. Several participants
commented that they used ‘pacing’ in the sense of bal-
ancing rest and activity within the context of other treat-
ments (eg, graded activity) but wished to emphasise that
they did not use pacing as a ‘stand-alone therapy’.
Dietary assessment and advice
Nineteen of 30 services (63%) reported that they gave
basic dietary advice, 15/30 (50%) reported that they
assessed patients for adequate nutrition and 24/30 ser-
vices (80%) could refer patients to a dietician where
necessary. No service recommended exclusion diets
unless the patient had been assessed and advised by an
immunologist or gastroenterologist. Where services did
report giving advice on diet, this was related to basic
healthy eating (eg, drinking enough ﬂuid, adequate
fruit and vegetables, reducing caffeine intake).
Treatment duration
Sixteen of 30 (53%) services reported that duration of
treatment and follow-up was based on individual patient
need, which could range between a single visit to
ongoing support. Since many services reported a high
level of individualisation to patient need, we did not cal-
culate mean duration or number of sessions.
Health professionals involved in delivering care
The smallest clinical care team consisted of one doctor
and one clinical psychologist. All other services (29/30,
97%) reported multidisciplinary teams (MDTs) involving
three or more different health professionals. Doctors
were the most common MDT members; 27/30 (90%)
services had either a consultant or a GP with special
Table 1 Therapeutic approaches used (in combination)
by CFS/ME services for severely affected patients
Therapy
Number of
services using
this approach
Percentage of
services using
this approach
Activity
management
28 93
CBT 25 83
Graded activity 24 80
Mindfulness
therapy
22 73
Lifestyle
management
22 73
Dietary advice 21 70
Pacing (within
graded activity, not
adaptive pacing)
17 57
Graded exercise
therapy
13 43
Counselling 10 33
CBT, cognitive–behavioural therapy; CFS/ME, chronic fatigue
syndrome/myalgic encephalomyelitis.
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interests on the team. The three services which did not
have their own doctor (3/30, 10%), reported that they
received medical input from doctors based in neigh-
bouring teams.
Occupational therapists were the second most
common MDT members. Table 2 shows results for this
question.
Measurement of outcomes
Twenty of 30 services (66%) used some or all of the
CFS/ME National Outcomes Database (NOD) question-
naires. These include patient-reported outcome mea-
sures on fatigue (Chalder Fatigue Scale),10 physical
function (SF-36),11 mood (Hospital Anxiety and
Depression Scale; HADS),12 pain (visual analogue pain
rating scale), sleepiness (Epworth Sleepiness Scale)13
and quality of life (EQ-5D).14 Other services used one
or more of the NOD outcome measures listed above,
plus additional outcome measures including the Work
and Social Adjustment Scale.15
General practitioner information
Twenty-ﬁve of 30 (83%) services reported that they had
taken action to provide GPs with information about what
their service provided, for example, by presentations at
GP training events.
The questionnaire also included a free-text question
on participants’ views on barriers to service provision for
severely affected patients. This data will be the subject of
a separate qualitative paper.
DISCUSSION
This study found from the responses to the question-
naire emailed between February and March 2013 that
while 55% of adult CFS/ME services in the NHS in
England treated severely affected patients, 33% did not,
with the remaining services offering regular but minimal
(by email or telephone) or occasional assistance to this
patient group. This suggests that a substantial proportion
of patients with severe CFS/ME lack access to
face-to-face, local specialist care, even when they live in
an area with a CFS/ME service.
This study received replies from all 49 specialist adult
CFS/ME NHS services in England as identiﬁed by
BACME in February 2013. This list was checked against
lists of specialist services available from national ME
support groups to ensure that all specialist CFS/ME ser-
vices had been identiﬁed and contacted. Most respon-
ders provided complete answers and the few instances of
missing data were completed by further contact with the
service. Therefore we have conﬁdence that these results
present an accurate picture of NHS service provision by
specialist CFS/ME services in England in spring 2013.
Is there evidence that severely affected patients with
CFS/ME without a local service can access specialist care
from other areas? Our scoping exercise found that 12
services accepted extracontractual referrals for severe
CFS/ME. However, it is important to note that since
travel presents a major barrier to housebound patients,
out-of-area referrals may be of limited use for this
patient group unless inpatient stay is offered. This study
identiﬁed only one NHS specialist inpatient unit in
England providing treatment for patients with CFS/ME.
This eight-bed unit accepts referrals from across the UK.
The authors are also aware of several non-NHS (private
or charitable) inpatient facilities which have recently
accepted NHS funded referrals for severe CFS/ME, a
development which highlights changes in the NHS com-
missioning landscape.
How does this compare with access to treatment for
patients with mild-to-moderate CFS/ME? In 2012, Collin
et al
7 collected data from 46/49 (93%) specialist CFS/
ME services and found that while 85% of (former)
primary care trusts provided a specialist CFS/ME
service, 8% did not (7% services did not respond to
survey). If the outcomes of the current scoping exercise
are combined with those of Collin et al, it would appear
that over a third of the population of patients with
severe CFS/ME in England lack access to local specialist
care for their condition.
How many patients in England may be affected by this
lack of access to specialist care? There has been little
national research on the current prevalence of severe
CFS/ME. In 2004 a study was conducted in Dorset in
which a postal questionnaire was sent to all patients on
the clinical records for the Dorset CFS/ME Service and
all members of the Dorset ME Support Group.16 Patients
identiﬁed as housebound then received a formal tele-
phone screening by an experienced CFS/ME doctor to
determine whether they fulﬁlled CDC Control 1994 cri-
teria for CFS/ME9 and Cox and Findley8 criteria for
severe/very severe CFS/ME. A key limitation was that the
Table 2 Health professionals on the multidisciplinary
team among the 30 CFS/ME services which provide
services for severely affected patients
Health professionals
within multidisciplinary
teams
Number of
services
Percentage of
services
Doctor 27 90
Occupational therapist 26 87
Physiotherapist 18 60
Clinical psychologist 15 50
Specialist nurse 6 20
Counsellor 3 10
Dietician 3 10
Clinical psychology
assistant or mental health
practitioner
3 10
Cognitive–behavioural
therapist
3 10
Peer specialist (individuals
with experience of getting
better from CFS/ME
3 10
CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis.
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study surveyed only patients who were known either to
the Dorset ME Support Group or to the Dorset CFS/ME
Service. For this reason some cases may have remained
unidentiﬁed. The study found 48 severely affected
patients with CFS/ME within a single county (Dorset) in
2004. It is not possible to ascertain from current evidence
whether case distribution is even across the UK or
whether the prevalence of severe CFS/ME has remained
stable over the past decade. Further research is needed to
obtain systematic evidence on prevalence so that the
number of patients currently affected by severe CFS/ME
in the UK can be accurately determined.
The 2007 NICE guidelines on CFS/ME recommend
referral of all severely affected patients for individualised
therapeutic management and monitoring/management
of clinical risk by health professionals with specialist
expertise in CFS/ME.1 The ﬁndings of this study suggest
that this recommendation is not currently being met.
However, results from those services that do provide help
for severe CFS/ME suggest that treatment is being offered
in accordance with 2007 NICE guidelines1 including the
use of MDTs and treatment individualised to patients
including activity management, CBT and graded activity.
CONCLUSION
This scoping exercise highlights a lack of access to spe-
cialist care for patients who are housebound and unable
to access outpatient services due to severe CFS/ME.
From the ﬁndings of this study we suggest that the devel-
opment of clinical services for severely affected patients
requires rigorous research to determine optimal prac-
tice, so that evidence-based interventions can be funded
and offered to all patients with severe CFS/ME.
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